ZyVersa Therapeutics Announces Publication Showing AIM2 and NLRP3 Inflammasomes Promote Atherosclerosis in Diabetes, Supporting IC 100’s Rationale for Targeting ASC to Inhibit Multiple Inflammasome Pathways
December 06, 2023 07:20 ET
|
ZyVersa Therapeutics
AIM2 and NLRP3 inflammasome activation leads to development of atherosclerotic lesions in diabetic mice.
Living with diabetes for decades
December 05, 2023 08:00 ET
|
Norton Healthcare
LOUISVILLE, Ky., Dec. 05, 2023 (GLOBE NEWSWIRE) -- In her new book, “Diabetes and Me: Living a Healthy and Empowered Life in the Face of Diabetes” (ISBN-13 9781633310803, Nov. 14, 2023),...
Digital Biomarkers Market revenue to hit USD 83.8 Billion by 2035, says Research Nester
December 05, 2023 06:00 ET
|
Research Nester
New York , Dec. 05, 2023 (GLOBE NEWSWIRE) -- The global digital biomarkers market size is expected to expand at 32.15% CAGR from 2023 to 2035. The market is anticipated to garner a revenue of USD...
GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
November 30, 2023 17:39 ET
|
GlucoTrack, Inc.
Rutherford, NJ, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with...
Avricore Health Corporate Update – Company Demonstrates Strong Growth
November 30, 2023 12:58 ET
|
Avricore Health Inc.
Avricore Health provides a corporate update and results for the first 9 months of 2023.
AHCO NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages AdaptHealth Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AHCO
November 24, 2023 20:15 ET
|
The Rosen Law Firm PA
NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of AdaptHealth Corp. (NASDAQ: AHCO) between (1) August 4,...
Cannabidiol Market Size Worth USD 46.47 Billion in 2032 | Emergen Research
November 15, 2023 12:21 ET
|
Emergen Research
Vancouver, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The global Cannabidiol (CBD) market size was USD 3.86 Billion in 2022 and is expected to register a rapid revenue CAGR of 28.3% during the forecast...
ACADEMY OF NUTRITION AND DIETETICS URGES CONGRESS: PASS BILL TO INCREASE ACCESS TO NUTRITION CARE
November 15, 2023 09:00 ET
|
Academy of Nutrition and Dietetics
Chicago, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The Academy of Nutrition and Dietetics supports and advocates for expanded access to medical nutrition therapy and additional coverage for more chronic...
Season Health Receives Recognition for Proven Clinical Outcomes in Diabetes and Food-as-Medicine Certification
November 08, 2023 10:15 ET
|
Season Health
Austin, TX, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Season Health, an integrated Food-as-Medicine platform that combines evidence-based clinical care with access to affordable medically-tailored meals and...
Type 2 Diabetes and prediabetes can be reversed with personalized lifestyle education and support from LifestyleRx and LifeLabs
November 07, 2023 12:00 ET
|
LifeLabs
Toronto, Ontario, Nov. 07, 2023 (GLOBE NEWSWIRE) -- LifeLabs is pleased to announce its partnership with LifestyleRx to offer Canadians greater support in managing their health with prediabetes and...